Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy
about
Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathiesRole of Imaging Techniques for Diagnosis, Prognosis and Management of Heart Failure Patients: Cardiac Magnetic Resonance.Fast 3-Breath-Hold 3-Dimensional Tagging Cardiac Magnetic Resonance in Patients with Hypertrophic Myocardial Diseases: A Feasibility Study.Late Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy.Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.Role of Cardiac MR Imaging in CardiomyopathiesThe emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease.Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update.Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy.The role of magnetic resonance imaging in hypertrophic cardiomyopathy.Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic CardiomyopathyPrediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitationAbnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: a marker of advanced disease and electrical myocardial instability.Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.Delayed enhancement cardiac computed tomography for the assessment of myocardial infarction: from bench to bedsideMicrovascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement.Clinical Characteristics and Prognosis of End-stage Hypertrophic CardiomyopathyLate gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry diseaseImpact of the papillary muscles on cardiac magnetic resonance image analysis of important left ventricular parameters in hypertrophic cardiomyopathyAmbulatory Monitoring and Arrhythmic Outcomes in Pediatric and Adolescent Patients With Duchenne Muscular Dystrophy.Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy.Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis.Electrophysiology Updates in Adult Congenital Heart Disease.Late Gadolinium Enhancement Amount As an Independent Risk Factor for the Incidence of Adverse Cardiovascular Events in Patients with Stage C or D Heart FailureEchocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy.The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy.Clinical topic: Nuclear imaging in hypertrophic cardiomyopathy.The role of echocardiography in hypertrophic cardiomyopathy.Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.Cardiac magnetic resonance in clinical cardiologyRole of non-invasive imaging in the work-up of cardiomyopathies.Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.
P2860
Q26765173-85B6F535-118A-4954-B2B0-F66DED1A4914Q26829719-BE2ECD50-0785-47E6-8DE9-A021AE309FE7Q27313679-AA7CD12A-CFA2-4D31-B7CB-A928B080059FQ30251600-30B357DE-7DC7-4231-8409-75F67F0BD88CQ30278822-4C19FBED-BCC1-41C3-88D0-7855C6C96644Q30279246-8B220FDB-7FD3-4343-93CD-4DB62003229BQ30355765-62F48E91-E3E2-42B8-8A16-270097A3D03BQ30371882-934A5797-A01F-435F-8B55-72F28C4CA578Q30376835-6E28D79F-3894-4525-8D84-3E5589AF77F6Q30426380-9725AFEC-34FB-4414-B351-B908658AE5A0Q33166075-B5016AC7-E04E-46A7-823B-392DCE9E3C8CQ33168755-315B3F63-66B2-4414-8101-C19AD9106AA8Q33595504-262366A7-C853-49A5-BDAC-915AF8CF5CAAQ33729245-E2BB8598-75EE-48BA-8075-18E19E67404CQ34428462-F65A54B8-443C-4209-AF96-2F356E8A70FDQ35893689-C2C36C59-C035-4F47-BCE8-2368EA7E1E10Q36059907-86C0B0F0-F626-4568-9045-11E2B3A8FA26Q36379549-BE3C3163-5733-495B-A982-ABD46AA82112Q36466791-7D824AC4-75AF-4C16-AFC9-085D32D56285Q36523287-CF542599-CA82-49A9-BB79-D8BFE9AD8457Q36571308-758C86FD-2B94-4E8A-AD98-E9C7BF265B31Q36758364-31F56888-1360-4B66-A10B-2BBB43E36AC4Q36823433-B6A77AE2-AB18-4FD7-8AF5-C084172B7277Q36877691-59E0AE87-F4EF-4794-89D8-493B71FCD4EAQ36912437-BE280CB8-D7E3-459D-A267-C3C6226332FDQ37156444-4D8F74FB-B64B-43C5-97E7-946743687D18Q37344566-9527828D-779B-44A0-9CAF-46ED6D4D5FDDQ37373426-FB2CECC0-1D5A-4CC3-8F53-B5198E2B128FQ37448546-4CA5EB95-8CD2-43A7-B1F7-8E1EB62676C7Q37596065-36AF7894-CDD1-4B07-8EA8-432FF21681C8Q37652430-CA2FA23A-5A0A-4944-A63E-76E757B591EEQ37741732-0D6A51F6-498E-476A-B0EE-A3EE1D2B74DEQ38303465-14373389-4FA0-4E6D-8F7A-11A9263AA39EQ38331109-0C11C1BE-494B-431F-BC1B-35533B6743D6Q38336102-FC641415-2C8E-4B37-82AC-9225D0B2C203Q38336304-0E2B3A24-AF8A-46C2-99A0-27841F3FB939Q38338232-BB810B93-F21D-444E-9767-11B3FF555A19Q38343713-D32BCC16-A336-4AF7-A80B-1654D2873C04Q38379334-124BEEAD-0B15-4560-8E20-A4B8526A3642Q38417406-B09F8F2E-D700-4CEC-91DF-ADCF1B3F94F1
P2860
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy
description
article
@en
im August 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2014
@uk
name
Prognostic value of quantitati ...... th hypertrophic cardiomyopathy
@en
Prognostic value of quantitati ...... th hypertrophic cardiomyopathy
@nl
type
label
Prognostic value of quantitati ...... th hypertrophic cardiomyopathy
@en
Prognostic value of quantitati ...... th hypertrophic cardiomyopathy
@nl
prefLabel
Prognostic value of quantitati ...... th hypertrophic cardiomyopathy
@en
Prognostic value of quantitati ...... th hypertrophic cardiomyopathy
@nl
P2093
P50
P1433
P1476
Prognostic value of quantitati ...... th hypertrophic cardiomyopathy
@en
P2093
Andrew M Crean
Barry J Maron
Benedetta Tomberli
C Michael Gibson
Christiane Gruner
E Francis Cook
Ethan Rowin
Evan Appelbaum
Francesco Formisano
Franco Cecchi
P304
P356
10.1161/CIRCULATIONAHA.113.007094
P407
P577
2014-08-01T00:00:00Z